http://main.pslgroup.com/news/content.nsf/MedicalNews/852576140048867C85257960008175CA
Cardiovascular Events Lower in Patients With Diabetes Taking Sitagliptin Versus a Sulphonylurea: Presented at IDF
"The investigators concluded that the incidence of CV events was lower in patients treated with sitagliptin compared with sulphonylureas. They cautioned that more research is warranted and they noted the effect of sitagliptin on CV outcomes currently is being evaluated prospectively in a randomised, placebo-controlled trial."
Cardiovascular Events Lower in Patients With Diabetes Taking Sitagliptin Versus a Sulphonylurea: Presented at IDF
"The investigators concluded that the incidence of CV events was lower in patients treated with sitagliptin compared with sulphonylureas. They cautioned that more research is warranted and they noted the effect of sitagliptin on CV outcomes currently is being evaluated prospectively in a randomised, placebo-controlled trial."
